Carbamylated low-density lipoprotein induces endothelial dysfunction

Abnormal High-Density Lipoprotein Induces Endothelial Dysfunction via Activation of Toll-like Receptor-2

(2013) Thimoteus Speer et al.   IMMUNITY

Protein Carbamylation Predicts Mortality in ESRD

(2013) R. A. Koeth et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Carbamylation of Serum Albumin as a Risk Factor for Mortality in Patients with Kidney Failure

(2013) A. H. Berg et al.   Science Translational Medicine

Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis

(2012) Caroline S Fox et al.   LANCET

Risk of coronary events in people with chronic kidney disease compared with those with diabetes: a population-level cohort study

(2012) Marcello Tonelli et al.   LANCET

Carbamylated low-density lipoprotein induces oxidative stress and accelerated senescence in human endothelial progenitor cells

(2011) Julia Carracedo et al.   FASEB JOURNAL

Chronic Uremia Stimulates LDL Carbamylation and Atherosclerosis

(2010) E. O. Apostolov et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

S-glutathionylation uncouples eNOS and regulates its cellular and vascular function

(2010) Chun-An Chen et al.   NATURE

Scavenger Receptors of Endothelial Cells Mediate the Uptake and Cellular Proatherogenic Effects of Carbamylated LDL

(2009) Eugene O. Apostolov et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY